Esophageal cancer represents one of the most challenging and often overlooked digestive system malignancies, developing in the tube that connects your throat to your stomach. This aggressive disease ...

In June, Newport Beach, Calif.-based Hoag b e came the first hospital in the U.S. to offer EsoGuard testing. The test is used by physicians to detect precancerous DNA changes in esophageal cells, ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely on ...

Preoperative CRT and chemotherapy significantly improve overall survival in AEG patients compared to surgery alone, reducing death risk by 25% and 22%, respectively. Both treatment modalities show ...

Esophageal cancer is classified into adenocarcinoma and squamous cell carcinoma, with dysphagia as a common symptom. Diagnosis involves endoscopy, biopsy, and imaging to confirm cancer presence and ...

The incidence of adenocarcinoma of the esophagus is rising rapidly in Western Europe and North America. It is an aggressive disease with early lymphatic and hematogenous dissemination. TNM cancer ...

At a median follow-up of 55 months in the intent-to-treat population of the ESOPEC trial, the FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) perioperative protocol significantly ...

Please provide your email address to receive an email when new articles are posted on . The researchers’ three-biomarker algorithm successfully identified esophageal cancer, BE and high-grade ...

For patients with Barrett esophagus, anti-reflux surgery may not reduce but rather increase the risk of esophageal cancer compared with anti-reflux medication, a new study suggests. Researchers ...